tiprankstipranks
Repligen Announces Major Leadership Changes and Roles
Company Announcements

Repligen Announces Major Leadership Changes and Roles

Don't Miss Our Christmas Offers:

The latest update is out from Repligen (RGEN).

Repligen Corporation has announced a significant leadership change with Tony J. Hunt stepping down as CEO to become the Executive Chair. Olivier Loeillot, currently President and Chief Commercial Officer, will take over as CEO starting September 1, 2024. Additionally, Karen A. Dawes will transition from her position as the Chair of the board to Lead Independent Director on the same date. This strategic shift in roles marks a new chapter for Repligen as it continues to navigate the evolving financial markets.

For detailed information about RGEN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyRepligen initiated with a Hold at Canaccord
TheFlyBioLife Solutions appoints Hunt to board of directors
TheFlyRepligen launches AVIPure dsRNA Clear OPUS columns
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App